progressing

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The list of health benefits tied to the diabetes … Read more